We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CUE market cap is 68.42M. The company's latest EPS is USD -0.8008 and P/E is -1.35.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.38M | 2.1M | 1.82M | 1.72M | 2.66M |
| Operating Income | -13.52M | -11.42M | -13.68M | -12.67M | -10.38M |
| Net Income | -13.19M | -10.91M | -13.53M | -12.35M | -10.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.46M | 3.15M | 14.94M | 1.25M | 5.49M |
| Operating Income | -36.77M | -45.04M | -43.71M | -53.5M | -51.99M |
| Net Income | -36.7M | -44.79M | -44.16M | -53.01M | -50.73M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 73.16M | 68.89M | 61.53M | 53.95M | 42.33M |
| Total Liabilities | 27.16M | 26.22M | 24.45M | 23.91M | 20.71M |
| Total Equity | 46M | 42.67M | 37.09M | 30.04M | 21.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 71.61M | 99.53M | 83.4M | 91.28M | 61.53M |
| Total Liabilities | 17.02M | 20.62M | 17.91M | 25.6M | 24.45M |
| Total Equity | 54.58M | 78.91M | 65.49M | 65.68M | 37.09M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.2M | -29M | -39.96M | -9.78M | -19.77M |
| Investing | 20M | 25M | 25M | -55k | -65k |
| Financing | 2.49M | 7.08M | 11.86M | 2.35M | 1.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.8M | -32.49M | -38.84M | -41.81M | -39.96M |
| Investing | 3.45M | 4.46M | 9.11M | -24.61M | 25M |
| Financing | 50.79M | 58.61M | 19.23M | 53.66M | 11.86M |
| Market Cap | 68.42M |
| Price to Earnings Ratio | -1.35 |
| Price to Sales Ratio | 12.46 |
| Price to Cash Ratio | 1.41 |
| Price to Book Ratio | 1.84 |
| Dividend Yield | - |
| Shares Outstanding | 63.35M |
| Average Volume (1 week) | 308.16k |
| Average Volume (1 Month) | 305.35k |
| 52 Week Change | -63.76% |
| 52 Week High | 3.20 |
| 52 Week Low | 0.45 |
| Spread (Intraday) | 0.17 (14.78%) |
| Company Name | Cue Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cuebiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
